These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14563452)

  • 1. Hyperlipidemic profiles during remission in childhood idiopathic nephrotic syndrome.
    Mérouani A; Lévy E; Mongeau JG; Robitaille P; Lambert M; Delvin EE
    Clin Biochem; 2003 Oct; 36(7):571-4. PubMed ID: 14563452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of serum lipid abnormalities in children with idiopathic nephrotic syndrome.
    Zilleruelo G; Hsia SL; Freundlich M; Gorman HM; Strauss J
    J Pediatr; 1984 Jan; 104(1):61-4. PubMed ID: 6690676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperlipidemia in childhood idiopathic nephrotic syndrome during initial remission and relapse.
    Mahmud S; Jahan S; Hossain MM
    Mymensingh Med J; 2011 Jul; 20(3):402-6. PubMed ID: 21804502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotic origin hyperlipidemia, relative reduction of vitamin E level and subsequent oxidative stress may promote atherosclerosis.
    Skrzep-Poloczek B; Tomasik A; Tarnawski R; Hyla-Klekot L; Dyduch A; Wojciechowska C; Wesolowski W; Kopieczna-Grzebieniak E; Zalejska-Fiolka J; Widera E
    Nephron; 2001 Sep; 89(1):68-72. PubMed ID: 11528235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma inhibition of lymphocyte proliferation in nephrotic syndrome: correlation with hyperlipidemia.
    Lenarsky C; Jordan SC; Ladisch S
    J Clin Immunol; 1982 Oct; 2(4):276-81. PubMed ID: 7142366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlipidemia in childhood nephrotic syndrome.
    Thabet MA; Salcedo JR; Chan JC
    Pediatr Nephrol; 1993 Oct; 7(5):559-66. PubMed ID: 8251323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein profiles at different stages of the nephrotic syndrome.
    Querfeld U; Gnasso A; Haberbosch W; Augustin J; Schärer K
    Eur J Pediatr; 1988 Apr; 147(3):233-8. PubMed ID: 3391217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P; Lu L; Hu B; Du PF
    Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndrome.
    McKenzie IF; Nestel PJ
    J Clin Invest; 1968 Jul; 47(7):1685-95. PubMed ID: 5658595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.
    Joven J; Simó JM; Vilella E; Camps J; Espinel E; Villabona C
    Clin Chem; 1995 Jun; 41(6 Pt 1):908-13. PubMed ID: 7768011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of low density lipoproteins in nephrotic dyslipidemia: comparison of hypercholesterolemia alone and combined hyperlipidemia.
    Vega GL; Toto RD; Grundy SM
    Kidney Int; 1995 Feb; 47(2):579-86. PubMed ID: 7723244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome.
    Braschi S; Masson D; Rostoker G; Florentin E; Athias A; Martin C; Jacotot B; Gambert P; Lallemant C; Lagrost L
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2559-67. PubMed ID: 9409228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.
    Vuong TD; Stroes ES; Willekes-Koolschijn N; Rabelink TJ; Koomans HA; Joles JA
    Kidney Int; 1999 Mar; 55(3):1005-10. PubMed ID: 10027937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein distribution and composition in the human nephrotic syndrome.
    Muls E; Rosseneu M; Daneels R; Schurgers M; Boelaert J
    Atherosclerosis; 1985 Feb; 54(2):225-37. PubMed ID: 3986019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid and apolipoprotein levels in patients with nephrotic syndrome.
    Ohta T; Matsuda I
    Clin Chim Acta; 1981 Dec; 117(2):133-43. PubMed ID: 6796292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased fasting plasma acylation-stimulating protein concentrations in nephrotic syndrome.
    Ozata M; Oktenli C; Gulec M; Ozgurtas T; Bulucu F; Caglar K; Bingol N; Vural A; Ozdemir IC
    J Clin Endocrinol Metab; 2002 Feb; 87(2):853-8. PubMed ID: 11836332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome.
    He L; Wu P; Tan L; Le B; Du W; Shen T; Wu J; Xiang Z; Hu M
    Lipids Health Dis; 2017 Sep; 16(1):167. PubMed ID: 28877724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of plasma lipid levels by plasma viscosity in nephrotic rats.
    Yedgar S; Eilam O; Shafrir E
    Am J Physiol; 1985 Jan; 248(1 Pt 1):E10-4. PubMed ID: 3966545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein abnormalities in adult nephrotic syndrome.
    Ongajyooth L; Sirisalee K; Laohaphand T; Parichatiganond P; Shayakul C; Nilwarangkur S
    J Med Assoc Thai; 1993 Sep; 76(9):512-20. PubMed ID: 7964258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of adipokines in children with primary nephrotic syndrome and its association with hyperlipidemia.
    Zhang RX; Zhang X; Zhang BL; Liu ZF; Lin SX
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Aug; 23(8):828-834. PubMed ID: 34511173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.